Insurance - Diversified
Compare Stocks
5 / 10Stock Comparison
HIG vs HUM vs UNH vs TRV vs CB
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Insurance - Property & Casualty
Insurance - Property & Casualty
HIG vs HUM vs UNH vs TRV vs CB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Diversified | Medical - Healthcare Plans | Medical - Healthcare Plans | Insurance - Property & Casualty | Insurance - Property & Casualty |
| Market Cap | $36.49B | $29.67B | $335.60B | $64.62B | $125.37B |
| Revenue (TTM) | $28.76B | $137.20B | $449.71B | $48.83B | $59.77B |
| Net Income (TTM) | $4.06B | $1.13B | $12.04B | $6.29B | $10.31B |
| Gross Margin | 35.8% | 14.0% | 18.8% | 36.9% | 29.4% |
| Operating Margin | 13.8% | 1.0% | 4.2% | 16.0% | 21.8% |
| Forward P/E | 10.1x | 27.7x | 20.2x | 10.7x | 11.9x |
| Total Debt | $4.37B | $12.94B | $78.39B | $9.27B | $22.19B |
| Cash & Equiv. | $133M | $4.20B | $24.36B | $842M | $2.47B |
HIG vs HUM vs UNH vs TRV vs CB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Hartford Financ… (HIG) | 100 | 346.5 | +246.5% |
| Humana Inc. (HUM) | 100 | 57.6 | -42.4% |
| UnitedHealth Group … (UNH) | 100 | 121.3 | +21.3% |
| The Travelers Compa… (TRV) | 100 | 279.4 | +179.4% |
| Chubb Limited (CB) | 100 | 268.2 | +168.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HIG vs HUM vs UNH vs TRV vs CB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HIG has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 233.5% 10Y total return vs TRV's 201.4%
- Lower volatility, beta 0.29, Low D/E 23.0%, current ratio 17.65x
- Beta 0.29, yield 1.6%, current ratio 17.65x
- Lower P/E (10.1x vs 10.7x), PEG 0.44 vs 0.51
HUM is the clearest fit if your priority is growth exposure.
- Rev growth 10.1%, EPS growth -1.4%, 3Y rev CAGR 11.7%
UNH is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- 11.8% revenue growth vs TRV's 5.2%
- 2.4% yield, 25-year raise streak, vs HIG's 1.6%
TRV ranks third and is worth considering specifically for stability and momentum.
- Beta 0.22 vs UNH's 0.59, lower leverage
- +12.8% vs UNH's -3.2%
CB is the clearest fit if your priority is valuation efficiency.
- PEG 0.44 vs TRV's 0.51
- Combined ratio 0.8 vs HUM's 1.0 (lower = better underwriting)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.8% revenue growth vs TRV's 5.2% | |
| Value | Lower P/E (10.1x vs 10.7x), PEG 0.44 vs 0.51 | |
| Quality / Margins | Combined ratio 0.8 vs HUM's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.22 vs UNH's 0.59, lower leverage | |
| Dividends | 2.4% yield, 25-year raise streak, vs HIG's 1.6% | |
| Momentum (1Y) | +12.8% vs UNH's -3.2% | |
| Efficiency (ROA) | 4.8% ROA vs HUM's 2.2%, ROIC 16.3% vs 4.1% |
HIG vs HUM vs UNH vs TRV vs CB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HIG vs HUM vs UNH vs TRV vs CB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HIG leads in 3 of 6 categories
CB leads 1 • UNH leads 1 • HUM leads 0 • TRV leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 15.6x HIG's $28.8B. CB is the more profitable business, keeping 17.2% of every revenue dollar as net income compared to HUM's 0.8%. On growth, HUM holds the edge at +23.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $28.8B | $137.2B | $449.7B | $48.8B | $59.8B |
| EBITDAEarnings before interest/tax | $4.3B | $2.2B | $23.2B | $8.5B | $13.3B |
| Net IncomeAfter-tax profit | $4.1B | $1.1B | $12.0B | $6.3B | $10.3B |
| Free Cash FlowCash after capex | $5.8B | $1.3B | $19.7B | $7.9B | $13.5B |
| Gross MarginGross profit ÷ Revenue | +35.8% | +14.0% | +18.8% | +36.9% | +29.4% |
| Operating MarginEBIT ÷ Revenue | +13.8% | +1.0% | +4.2% | +16.0% | +21.8% |
| Net MarginNet income ÷ Revenue | +14.1% | +0.8% | +2.7% | +12.9% | +17.2% |
| FCF MarginFCF ÷ Revenue | +20.2% | +0.9% | +4.4% | +16.2% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.1% | +23.5% | +2.0% | +3.5% | +7.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +40.9% | -4.6% | +0.7% | +23.4% | +28.0% |
Valuation Metrics
HIG leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 10.0x trailing earnings, HIG trades at a 64% valuation discount to UNH's 27.9x P/E. Adjusting for growth (PEG ratio), HIG offers better value at 0.44x vs TRV's 0.52x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $36.5B | $29.7B | $335.6B | $64.6B | $125.4B |
| Enterprise ValueMkt cap + debt − cash | $40.7B | $38.4B | $389.6B | $73.0B | $145.1B |
| Trailing P/EPrice ÷ TTM EPS | 9.96x | 25.12x | 27.95x | 10.90x | 12.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.06x | 27.68x | 20.19x | 10.69x | 11.87x |
| PEG RatioP/E ÷ EPS growth rate | 0.44x | — | — | 0.52x | 0.46x |
| EV / EBITDAEnterprise value multiple | 7.90x | 16.87x | 16.70x | 8.62x | 10.87x |
| Price / SalesMarket cap ÷ Revenue | 1.29x | 0.23x | 0.75x | 1.32x | 2.10x |
| Price / BookPrice ÷ Book value/share | 2.00x | 1.68x | 3.31x | 2.07x | 1.60x |
| Price / FCFMarket cap ÷ FCF | 6.34x | 79.13x | 20.88x | — | 8.62x |
Profitability & Efficiency
HIG leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
HIG delivers a 22.0% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $6 for HUM. HIG carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), HIG scores 9/9 vs HUM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +22.0% | +6.2% | +11.5% | +19.1% | +13.6% |
| ROA (TTM)Return on assets | +4.8% | +2.2% | +3.9% | +4.4% | +4.0% |
| ROICReturn on invested capital | +16.3% | +4.1% | +9.2% | +15.3% | +10.8% |
| ROCEReturn on capital employed | +5.7% | +4.0% | +9.7% | +8.6% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 5 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.23x | 0.73x | 0.77x | 0.28x | 0.28x |
| Net DebtTotal debt minus cash | $4.2B | $8.7B | $54.0B | $8.4B | $19.7B |
| Cash & Equiv.Liquid assets | $133M | $4.2B | $24.4B | $842M | $2.5B |
| Total DebtShort + long-term debt | $4.4B | $12.9B | $78.4B | $9.3B | $22.2B |
| Interest CoverageEBIT ÷ Interest expense | 20.73x | 3.08x | 4.71x | 19.34x | 18.07x |
Total Returns (Dividends Reinvested)
HIG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIG five years ago would be worth $21,271 today (with dividends reinvested), compared to $5,674 for HUM. Over the past 12 months, TRV leads with a +12.8% total return vs UNH's -3.2%. The 3-year compound annual growth rate (CAGR) favors HIG at 25.3% vs HUM's -21.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -2.8% | -6.2% | +10.6% | +5.2% | +3.9% |
| 1-Year ReturnPast 12 months | +5.6% | -1.0% | -3.2% | +12.8% | +12.0% |
| 3-Year ReturnCumulative with dividends | +96.9% | -51.9% | -19.9% | +70.6% | +66.4% |
| 5-Year ReturnCumulative with dividends | +112.7% | -43.3% | -2.6% | +98.2% | +92.1% |
| 10-Year ReturnCumulative with dividends | +233.5% | +59.8% | +220.6% | +201.4% | +187.6% |
| CAGR (3Y)Annualised 3-year return | +25.3% | -21.7% | -7.1% | +19.5% | +18.5% |
Risk & Volatility
Evenly matched — TRV and CB each lead in 1 of 2 comparable metrics.
Risk & Volatility
CB is the less volatile stock with a -0.01 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRV currently trades 95.4% from its 52-week high vs HUM's 78.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | 0.61x | 0.59x | 0.21x | -0.02x |
| 52-Week HighHighest price in past year | $144.50 | $315.35 | $395.52 | $313.12 | $345.67 |
| 52-Week LowLowest price in past year | $119.61 | $163.11 | $234.60 | $249.19 | $264.10 |
| % of 52W HighCurrent price vs 52-week peak | +91.8% | +78.4% | +93.5% | +95.4% | +92.9% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 76.6 | 75.9 | 50.5 | 42.9 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 1.6M | 7.9M | 1.3M | 1.6M |
Analyst Outlook
UNH leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HIG as "Buy", HUM as "Hold", UNH as "Buy", TRV as "Hold", CB as "Buy". Consensus price targets imply 14.6% upside for HIG (target: $152) vs -0.5% for HUM (target: $246). For income investors, UNH offers the higher dividend yield at 2.35% vs CB's 1.18%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $152.00 | $246.00 | $385.43 | $313.00 | $344.33 |
| # AnalystsCovering analysts | 42 | 44 | 52 | 43 | 43 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +1.4% | +2.4% | +1.4% | +1.2% |
| Dividend StreakConsecutive years of raises | 15 | 0 | 25 | 20 | 9 |
| Dividend / ShareAnnual DPS | $2.07 | $3.56 | $8.70 | $4.30 | $3.80 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.4% | +0.5% | +1.7% | +4.8% | +2.9% |
HIG leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). CB leads in 1 (Income & Cash Flow). 1 tied.
HIG vs HUM vs UNH vs TRV vs CB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HIG or HUM or UNH or TRV or CB a better buy right now?
For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.
8% revenue growth year-over-year, versus 5. 2% for The Travelers Companies, Inc. (TRV). The Hartford Financial Services Group, Inc. (HIG) offers the better valuation at 10. 0x trailing P/E (10. 1x forward), making it the more compelling value choice. Analysts rate The Hartford Financial Services Group, Inc. (HIG) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HIG or HUM or UNH or TRV or CB?
On trailing P/E, The Hartford Financial Services Group, Inc.
(HIG) is the cheapest at 10. 0x versus UnitedHealth Group Incorporated at 27. 9x. On forward P/E, The Hartford Financial Services Group, Inc. is actually cheaper at 10. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Chubb Limited wins at 0. 44x versus The Travelers Companies, Inc. 's 0. 51x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HIG or HUM or UNH or TRV or CB?
Over the past 5 years, The Hartford Financial Services Group, Inc.
(HIG) delivered a total return of +112. 7%, compared to -43. 3% for Humana Inc. (HUM). Over 10 years, the gap is even starker: HIG returned +233. 5% versus HUM's +76. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HIG or HUM or UNH or TRV or CB?
By beta (market sensitivity over 5 years), Chubb Limited (CB) is the lower-risk stock at -0.
02β versus Humana Inc. 's 0. 61β — meaning HUM is approximately -3116% more volatile than CB relative to the S&P 500. On balance sheet safety, The Hartford Financial Services Group, Inc. (HIG) carries a lower debt/equity ratio of 23% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — HIG or HUM or UNH or TRV or CB?
By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.
8% versus 5. 2% for The Travelers Companies, Inc. (TRV). On earnings-per-share growth, the picture is similar: The Hartford Financial Services Group, Inc. grew EPS 28. 7% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, HUM leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HIG or HUM or UNH or TRV or CB?
Chubb Limited (CB) is the more profitable company, earning 17.
2% net margin versus 0. 9% for Humana Inc. — meaning it keeps 17. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CB leads at 21. 8% versus 1. 1% for HUM. At the gross margin level — before operating expenses — HIG leads at 46. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HIG or HUM or UNH or TRV or CB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Chubb Limited (CB) is the more undervalued stock at a PEG of 0. 44x versus The Travelers Companies, Inc. 's 0. 51x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Hartford Financial Services Group, Inc. (HIG) trades at 10. 1x forward P/E versus 27. 7x for Humana Inc. — 17. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HIG: 14. 6% to $152. 00.
08Which pays a better dividend — HIG or HUM or UNH or TRV or CB?
All stocks in this comparison pay dividends.
UnitedHealth Group Incorporated (UNH) offers the highest yield at 2. 4%, versus 1. 2% for Chubb Limited (CB).
09Is HIG or HUM or UNH or TRV or CB better for a retirement portfolio?
For long-horizon retirement investors, Chubb Limited (CB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
02), 1. 2% yield, +186. 2% 10Y return). Both have compounded well over 10 years (CB: +186. 2%, HUM: +76. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HIG and HUM and UNH and TRV and CB?
These companies operate in different sectors (HIG (Financial Services) and HUM (Healthcare) and UNH (Healthcare) and TRV (Financial Services) and CB (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HIG is a mid-cap deep-value stock; HUM is a mid-cap quality compounder stock; UNH is a large-cap quality compounder stock; TRV is a mid-cap deep-value stock; CB is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.